Review of Accounting Studies

, Volume 19, Issue 1, pp 1–42

Accounting and litigation risk: evidence from Directors’ and Officers’ insurance pricing

Article

DOI: 10.1007/s11142-013-9249-4

Cite this article as:
Cao, Z. & Narayanamoorthy, G.S. Rev Account Stud (2014) 19: 1. doi:10.1007/s11142-013-9249-4

Abstract

We study whether and how financial reporting concerns are priced by insurers that sell Directors’ and Officers’ (D&O) insurance to public firms. As D&O insurers typically assume the liabilities arising from shareholder litigation, the premiums they charge for D&O coverage reflect their assessment of a company’s litigation risk. Using a sample of public firms in the 2001–2004 Tillinghast D&O insurance surveys, we document that firms with lower earnings quality or prior accounting restatements pay higher premiums after controlling for other factors impacting litigation risk. In addition, insurers’ concerns about financial reporting are most evident for firms with restatements that are not revenue or expense related, are greater in the period following the passage of the Sarbanes–Oxley Act of 2002, and are greater for firms with financial reporting problems that linger. Our results are consistent with past restatements being viewed as evidence of chronic problems with a firm’s financial statements. By analyzing archival data, we can also quantify the effects of other determinants of D&O premiums (such as business risk, corporate governance, etc.) identified by Baker and Griffith (Univ Chic Law Rev 74(2):487–544, 2007a) through interviews regarding the D&O underwriting process.

JEL Classification

G22 G32 K22 K41 K42 M41 

Keywords

Financial reporting quality Accounting restatements Directors’ and Officers’ insurance Litigation risk D&O Corporate governance 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Milgard School of BusinessUniversity of Washington TacomaTacomaUSA
  2. 2.College of BusinessUniversity of Illinois at Urbana-ChampaignChampaignUSA

Personalised recommendations